Congratulations, Mr. Speaker, and to my colleague across the way.
I know of the member's interest with multiple sclerosis, which affects 55,000 to 75,000 Canadians. I know he is aware of new research that shows that the prevalence of chronic cerebrospinal venous insufficiency in MS is about 90%, that there have been over 12,500 procedures performed worldwide now in 50 countries, and that they are showing an improvement in the quality of life for MS patients.
We absolutely need evidence-based medicine in Canada. That means we must collect the evidence.
I would ask him, why the refusal to undertake a nationally-funded, multi-centred clinical trial to determine if treating CCSVI will improve the quality of life for MS patients?